Tower Research Capital (TRC)’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Buy |
|
|||||
|
2025
Q1 | $70.3K | Sell |
|
|||||
|
2024
Q4 | $194K | Buy |
|
|||||
|
2024
Q3 | $117K | Sell |
|
|||||
|
2024
Q2 | $392K | Buy |
|
|||||
|
2024
Q1 | $28.3K | Sell |
|
|||||
|
2023
Q4 | $70.1K | Sell |
|
|||||
|
2023
Q3 | $92.5K | Buy |
|
|||||
|
2023
Q2 | $66.6K | Buy |
|
|||||
|
2023
Q1 | $52K | Sell |
|
|||||
|
2022
Q4 | $135K | Sell |
|
|||||
|
2022
Q3 | $405K | Buy |
|
|||||
|
2022
Q2 | $227K | Buy |
|
|||||
|
2022
Q1 | $134K | Sell |
|
|||||
|
2021
Q4 | $293K | Buy |
|
|||||
|
2021
Q3 | $218K | Buy |
|
|||||
|
2021
Q2 | $83K | Buy |
|
|||||
|
2021
Q1 | $58K | Buy |
|
|||||
|
2020
Q4 | $47K | Sell |
|
|||||
|
2020
Q3 | $31K | Buy |
|